- Issuer ticker
-
TWST
- Reported as of
-
12 May 2026
- Net transaction value
-
-$673,440
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
14 May 2026, 16:05:09 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Kendra Fox, as Attorney-in-Fact for Jan Johannessen
Key filing fact
Jan Johannessen filed Form 4 for Twist Bioscience Corp (TWST) on 14 May 2026.
Key facts
- This page summarizes Jan Johannessen's Form 4 filing for Twist Bioscience Corp (TWST).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 14 May 2026, 16:05.
Change
- Previous filing in this sequence was filed on 09 Feb 2026.
- Current net transaction value: -$673,440.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001224168
Primary reporting owner
JOHANNESSEN JAN
- Relationship
-
Director
- Address
- C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD., SOUTH SAN FRANCISCO
- Signature
- /s/ Kendra Fox, as Attorney-in-Fact for Jan Johannessen
- Signature date
- 14 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TWST
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +12,000
- Change %
- +68%
- Price
-
$14.00*
- Shares after
- 29,754
- Date
- 12 May 2026
- Ownership
- Direct
TWST
transaction
Common Stock
Sale
- Transaction value
- $673,440
- Shares
- -12,000
- Change %
- -40%
- Price
-
$56.12
- Shares after
- 17,754
- Date
- 12 May 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TWST
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- +12,000
- Change %
- Price
-
$0.000000*
- Shares after
- 10,304
- Date
- 12 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,000
- Exercise price
- $14.00
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote